Oct 17, 2019
The Viral and Non-viral Vector Manufacturing Market is Anticipated to Grow at an Annualized Rate of Over 20%, Claims Roots Analysis
Oct 15, 2019
DNA Testing Company Earns Top Grades from TopConsumerReviews.com
Oct 10, 2019
Worldwide Viral Vector & Plasmid DNA Market, 2018-2019 & 2024, by Product Type, Application, End-use, and Geography
Sep 26, 2019
23andMe and TrialSpark Announce Joint Clinical Trial Offering and Request For Proposals
Sep 25, 2019
North America Genetic Testing Market to 2025: Focus on Predictive and Presymptomatic, Carrier, Prenatal and Newborn, Diagnostic, Pharmacogenomic Testing
Sep 20, 2019
Global & US Gene Therapy Market 2019-2020: Immunodeficiency Syndromes - The Focus of Gene Therapy
Sep 17, 2019
AskBio Acquires Assets from RoverMed BioSciences, Adds Nanotechnology Precision to Delivery of AAV Gene Therapeutics
Sep 16, 2019
Benitec Biopharma Provides Update on BB-301 Oculopharyngeal Muscular Dystrophy (OPMD) Program
Sep 11, 2019
deCODE in Iceland Agrees to Sequence Half of UK Biobanks Participants
Sep 09, 2019
Wize Pharma Enters Exclusive License Agreement for Ophthalmic Non-viral Gene Therapy Technology
Sep 04, 2019
REGENXBIO Announces Exclusive Worldwide Option and License Agreement with Clearside Biomedical for Evaluation of In-Office Delivery Platform for RGX-314
Sep 04, 2019
Locana appoints Kathie Bishop, Ph.D., as Chief Scientific Officer
Sep 04, 2019
The global direct-to-consumer genetic testing market at a CAGR of over 16% during the forecast period
Aug 30, 2019
Using Precision Engineering to Streamline Manufacturing of Next-Generation Cellular Therapies
Aug 27, 2019
Viralgen Receives cGMP Certification from European Medicines Agency
Aug 22, 2019
AskBio Applauds Pfizer's Continuing Investments in Gene Therapy
Aug 19, 2019
World Human Identification Markets Report 2019: 2018 Data, 2019 Estimates & CAGR Projections Through 2024
Aug 13, 2019
AskBio Acquires Synpromics Ltd. and Expands its Gene Therapy Technology Portfolio
Jul 24, 2019
REGENXBIO Expands Pipeline Using NAV Vectors to Deliver Therapeutic Antibodies for the Treatment of Hereditary Angioedema and Neurodegenerative Diseases
Jul 24, 2019
REGENXBIO and Neurimmune Announce Collaboration to Develop Vectorized Antibodies for the Treatment of Neurodegenerative Diseases